Recent consensus statements in pediatric endocrinology: a selective review

Michelle Klein1, Anpalakan Sathasivam, Yeray Novoa

  • 1Mount Sinai Hospital, New York, NY 10029, USA. michelle.klein@mssm.edu

Insights

This review synthesizes key recommendations from recent pediatric endocrinology consensus statements. It highlights evidence-based clinical guidelines for managing diverse endocrine conditions in children.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Guidelines
  • Evidence-Based Medicine

Background:

  • Clinical guidelines and consensus statements are crucial for organizing medical knowledge and guiding patient care.
  • Over 20 consensus statements were published in pediatric literature in 2008 alone, indicating a growing need for synthesized information.
  • These documents are essential for ensuring standardized and effective clinical management.

Purpose of the Study:

  • To summarize the most important points from recent consensus statements in pediatric endocrinology.
  • To provide accessible information on current best practices for clinical management.
  • To reflect the original intent and language of the statements developed by leading endocrine societies.

Main Methods:

  • Review and synthesis of recent consensus statements from major pediatric endocrine societies.
  • Focus on statements jointly developed by the Lawson Wilkins Society for Pediatric Endocrinology and the European Society for Pediatric Endocrinology.
  • Paraphrasing of original statements while maintaining their core meaning and intent.

Main Results:

  • Identification and summarization of salient recommendations from multiple pediatric endocrine consensus statements.
  • The article distills complex guidelines into key takeaways for clinicians.
  • Emphasis on the evidence-based nature of the recommendations.

Conclusions:

  • This summary provides a valuable resource for pediatric endocrinologists seeking to stay updated on clinical best practices.
  • The article facilitates the application of current evidence in daily pediatric endocrine patient management.
  • It underscores the collaborative efforts of international societies in advancing pediatric endocrine care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...